Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-02-07

Clinical Trial Update: Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial compares Roux-en-Y versus Billroth II reconstruction after subtotal gastrectomy in patients with gastric cancer and type 2 diabetes mellitus. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: feng Zheng | Conditions: Gastric Cancer, Type 2 Diabetes | Phase 2, Phase 3 | Status: UNKNOWN